| Analysis | Metabolite Name | Measured Value | Units | Treatment |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | 3-METHYL-2-OXOPENTANOIC ACID (M-H)- | 1286719 | Peak area | Control |
| Reversed phase NEGATIVE ION MODE | 3-METHYL-2-OXOPENTANOIC ACID (M-H)- | 1524677 | Peak area | DEHP treated |
| Reversed phase NEGATIVE ION MODE | 3-METHYL-2-OXOPENTANOIC ACID (M-H)- | 1527796 | Peak area | DEHP treated |
| Reversed phase NEGATIVE ION MODE | 3-METHYL-2-OXOPENTANOIC ACID (M-H)- | 1557782 | Peak area | Control |
| Reversed phase NEGATIVE ION MODE | 3-METHYL-2-OXOPENTANOIC ACID (M-H)- | 1617640 | Peak area | DEHP treated |
| Reversed phase NEGATIVE ION MODE | 3-METHYL-2-OXOPENTANOIC ACID (M-H)- | 1618461 | Peak area | DEHP treated |
| Reversed phase NEGATIVE ION MODE | 3-METHYL-2-OXOPENTANOIC ACID (M-H)- | 1738117 | Peak area | Control |
| Reversed phase NEGATIVE ION MODE | 3-METHYL-2-OXOPENTANOIC ACID (M-H)- | 1743515 | Peak area | Control |
| Reversed phase NEGATIVE ION MODE | 3-METHYL-2-OXOPENTANOIC ACID (M-H)- | 1838524 | Peak area | Control |
| Reversed phase NEGATIVE ION MODE | 3-METHYL-2-OXOPENTANOIC ACID (M-H)- | 1869190 | Peak area | DEHP treated |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|